Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06405464
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-04-15
Brief Title:
Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort StudyUptake Outcome and Risk Factors for Treatment Failures
Sponsor:
Organization:
University of Zurich
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
2 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Blood plasma and cell samples
Enrollment Count:
600
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 106741 |
Who Masked List: